Account wins

Share this article:
Centron has announced the following new agency of record assignments. Eisai has selected Centron as the advertising agency of record for their CTCL oncology portfolio, which includes ONTAK (denileukin diftitox), Targretin (bexarotene) capsules, and Targretin (bexarotene) gel 1.1%. Millennium Pharmaceuticals, has awarded Centron the advertising agency of record assignment for Velcade (bortezomib) for injection, their product for multiple myeloma and mantle cell lymphoma. Centron also announces that they have received additional assignments from Stiefel Laboratories, with agency of record assignments for Soriatane (acitretin), MimyX Cream, Olux-E (clobetasol propianate) Foam 0.05%, Verdeso (desonide) Foam, 0.05%, Olux (clobetasol propionate) Foam, 0.05%, and Luxiq (betamethasone valerate) Foam, 0.12%.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.